The
global pharmaceutical contract
manufacturing/contract research market is anticipated to reach USD
238.3 billion by 2025, according to a new report by Grand View Research, Inc.
Impact on the volume of capacity that is required for production due to of
increasing expression levels is anticipated to influence outsourcing industry.
Increased cell densities as well as increase in expression of each cell has led
to the steady decline in the volume requirement. The aforementioned fact
provides the client with choices for in selection from several CMOs, which was
not the fact earlier.
The
focus of large pharmaceutical companies to strategically engage with a small
number of preferred providers is a meaningful departure from the
procurement-based outsourcing. This was one of the many approaches that the
service industry had become accustomed to.
Expanding
market for biosimilars and biobetters is anticipated to pronounce the demand
for contract development and manufacturing support. Service providers that hold
the potential of providing cost as well as quality advantages are set to make
inroads and grow at tremendous pace in the forecast period.
However,
as drug manufacturers are increasing the investments with respect to production
capabilities. This may limit the potential growth of contract manufacturing
services to traditional customers thereby hampering industrial growth.
Browse full research report on Global Pharmaceutical Contract
Research Market: http://www.grandviewresearch.com/industry-analysis/pharmaceutical-contract-manufacturing-market
Further Key Findings
from the Report Suggest:
- Contract
manufacturing services estimated to dominate the market over research
services
- These
services are segmented on the basis of development of different forms of
formulations. Active Pharmaceutical Ingredient (API) / Bulk drugs
registered the largest share of revenue.
- Pharmaceutical
companies prefer the outsourcing services for API research and manufacture
- Factors
supportive for this trend includes reduction in the cost of production of
APIs
- Active
molecules from small companies are always acquired by the big
pharmaceutical companies
- The
prominent entities focus on marketing rather than core competencies of
production of API in order to maintain presence
- Finished
dose formulations are expected to register the fastest growth in the
coming years
- Contract
research services for oncology dominated the market and are anticipated to
maintain the dominance in the coming years
- CMOs/CDMOs
with the ability to establish facilities in emerging countries are
expected to drive growth
- Companies
can position themselves for strong growth, given that demand is expected
to expand rapidly in the coming years
- The major
countries include Brazil. Russia, India, and China as the contract service
sector is in its infancy in these regions
- Key players
contributing in this market are AbbVie Contract Manufacturing,
Catalent, Grifols International, S.A., Baxter BioPharma Solutions,
Boehringer Ingelheim Biopharmaceuticals Gmbh, Dalton Pharma Services, and
Patheon.
- Companies
are engaged in lifecycle management of small-molecule drugs through the
development of modified generics with uniquely enhanced properties
- Increased
competitiveness in the contract service sector is anticipated to
ultimately benefit the sector growth
Browse more reports of this category by
Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the pharmaceutical contract manufacturing & contract research
market on the basis of service types and region:
- Pharmaceutical Contract
Manufacturing/Contract Research Market, Service Types Outlook (Revenue,
USD Billion, 2014 - 2025)
- Manufacturing Services (CMO)
- API/Bulk Drugs
- Advanced Drug Delivery
Formulations Packaging
- Packaging
- Finished Dose Formulations
- Solid Formulations
- Liquid Formulations
- Semi-solid Formulations
- Research Services (CRO)
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
- Pharmaceutical Contract
Manufacturing/Contract Research Market Regional Outlook (Revenue, USD
Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- India
- China
- Latin America
- Brazil
- Mexico
- Colombia
- Argentina
- Chile
- Venezuela
- Middle East and Africa (MEA)
- South Africa
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment